How similar is similar enough? A sufficient similarity case study with Ginkgo biloba extract.

Botanical dietary supplements are complex mixtures that can be highly variable in composition and quality, making safety evaluation difficult. A key challenge is determining how diverse products in the marketplace relate to chemically and toxicologically characterized reference samples (i.e., how similar must a product be in order to be well-represented by the tested reference sample?). Ginkgo biloba extract (GBE) was used as a case study to develop and evaluate approaches for determining sufficient similarity. Multiple GBE extracts were evaluated for chemical and biological-response similarity. Chemical similarity was assessed using untargeted and targeted chemistry approaches. Biological similarity was evaluated using in vitro liver models and short-term rodent studies. Statistical and data visualization methods were then used to make decisions about the similarity of products to the reference sample. A majority of the 26 GBE samples tested (62%) were consistently determined to be sufficiently similar to the reference sample, while 27% were different from the reference GBE, and 12% were either similar or different depending on the method used. This case study demonstrated that approaches to evaluate sufficient similarity allow for critical evaluation of complex mixtures so that safety data from the tested reference can be applied to untested materials.

[1]  Rogelio Tornero-Velez,et al.  An Empirical Approach to Sufficient Similarity: Combining Exposure Data and Mixtures Toxicology Data , 2013, Risk analysis : an official publication of the Society for Risk Analysis.

[2]  Y. Tam,et al.  Quality control analyses for Ginkgo extracts require analysis of intact flavonol glycosides , 2020 .

[3]  P. Barnes,et al.  Trends in the use of complementary health approaches among adults: United States, 2002-2012. , 2015, National health statistics reports.

[4]  P. Braquet.  GINKGOLIDES: POTENT PLATELET ACTIVATING FACTOR ANTAGONISTS ISOLATED FROM GINKGO BILOBA L.: CHEMISTRY, PHARMACOLOGY AND CLINICAL APPLICATIONS , 1987 .

[5]  J. Bucher,et al.  Naturally complex: Perspectives and challenges associated with Botanical Dietary Supplement Safety assessment. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  G. Rice,et al.  Correlations of Water Quality Parameters with Mutagenicity of Chlorinated Drinking Water Samples , 2009, Journal of toxicology and environmental health. Part A.

[7]  H. Verhagen,et al.  Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba , 2010, Food & nutrition research.

[8]  Sergei Romanov,et al.  Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors , 2008, Nature Methods.

[9]  Lei Guo,et al.  Ginkgo biloba extract induces gene expression changes in xenobiotics metabolism and the Myc-centered network. , 2010, Omics : a journal of integrative biology.

[10]  S. Smith‐Roe,et al.  Black cohosh extracts and powders induce micronuclei, a biomarker of genetic damage, in human cells , 2018, Environmental and molecular mutagenesis.

[11]  I. Wanless,et al.  Mechanisms of liver involvement in systemic disease. , 2013, Best practice & research. Clinical gastroenterology.

[12]  K. Sasaki,et al.  Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2L GABAA receptors , 2004 .

[13]  Taosheng Chen,et al.  Small-molecule modulators of the constitutive androstane receptor , 2015, Expert opinion on drug metabolism & toxicology.

[14]  P. Feder,et al.  Evaluating the Similarity of Complex Drinking-Water Disinfection By-Product Mixtures: Overview of the Issues , 2009, Journal of toxicology and environmental health. Part A.

[15]  S. Elmore,et al.  Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies). , 2013, National Toxicology Program technical report series.

[16]  Devanand L. Luthria,et al.  Detection of adulterated Ginkgo biloba supplements using chromatographic and spectral fingerprints. , 2012, Journal of AOAC International.

[17]  K. Brouwer,et al.  Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity , 2010, Drug metabolism reviews.

[18]  Comparison of Flow Injection MS, NMR, and DNA Sequencing: Methods for Identification and Authentication of Black Cohosh (Actaea racemosa). , 2015, Planta medica.

[19]  H. Blume,et al.  Pharmaceutical quality of different Ginkgo biloba brands , 2002, The Journal of pharmacy and pharmacology.

[20]  G. Kissling,et al.  Toxicity and Carcinogenicity Studies of Ginkgo biloba Extract in Rat and Mouse , 2014, Toxicologic pathology.

[21]  N. Hewitt,et al.  Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro–in vivo correlations , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[22]  Fred A. Wright,et al.  A chemical–biological similarity-based grouping of complex substances as a prototype approach for evaluating chemical alternatives† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6gc01147k Click here for additional data file. , 2016, Green chemistry : an international journal and green chemistry resource : GC.

[23]  Y. Kodama,et al.  Essential role of constitutive androstane receptor in Ginkgo biloba extract induced liver hypertrophy and hepatocarcinogenesis. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  J. Lynch,et al.  Structure‐activity analysis of ginkgolide binding in the glycine receptor pore , 2008, Journal of neurochemistry.

[25]  F. V. Defeudis,et al.  A Brief History of EGb 761® and its Therapeutic Uses , 2003, Pharmacopsychiatry.

[26]  Mark J Nicolich,et al.  The relationship between developmental toxicity and aromatic-ring class profile of high-boiling petroleum substances. , 2013, Regulatory toxicology and pharmacology : RTP.

[27]  Bo-Yang Yu,et al.  Quality control of flavonoids in Ginkgo biloba leaves by high-performance liquid chromatography with diode array detection and on-line radical scavenging activity detection. , 2009, Journal of chromatography. A.

[28]  G. Rajaraman,et al.  Species-Dependent and Receptor-Selective Action of Bilobalide on the Function of Constitutive Androstane Receptor and Pregnane X Receptor , 2012, Drug Metabolism and Disposition.

[29]  Pieter A. Cohen.  The Supplement Paradox: Negligible Benefits, Robust Consumption. , 2016, JAMA.

[30]  Y. Shimizu.  Liver in systemic disease. , 2008, World journal of gastroenterology.

[31]  AOAC INTERNATIONAL guidelines for validation of botanical identification methods. , 2012, Journal of AOAC International.

[32]  R. Bauer,et al.  The relevance of pharmacognosy in pharmacological research on herbal medicinal products , 2015, Epilepsy & Behavior.

[33]  T. V. van Beek,et al.  Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. , 2009, Journal of chromatography. A.

[34]  Y. Kodama,et al.  In vivo genotoxicity of Ginkgo biloba extract in gpt delta mice and constitutive androstane receptor knockout mice. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  Robert J Kavlock,et al.  Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program. , 2010, Chemical research in toxicology.

[36]  K. Witt,et al.  An ethanolic extract of black cohosh causes hematological changes but not estrogenic effects in female rodents. , 2012, Toxicology and applied pharmacology.

[37]  J. Harnly,et al.  Chromatographic profiles and identification of new phenolic components of Ginkgo biloba leaves and selected products. , 2008, Journal of agricultural and food chemistry.